SEARCH

SEARCH BY CITATION

References

  • Bonneville, M. & Scotet, E. (2006) Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors. Current Opinion in Immunology, 18, 539546.
  • Chen, T., Berenson, J., Vescio, R., Swift, R., Gilchick, A., Goodin, S., LoRusso, P., Ma, P., Ravera, C., Deckert, F., Schran, H., Seaman, J. & Skerjanec, A. (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. Journal of Clinical Pharmacology, 42, 12281236.
  • Gober, H.J., Kistowska, M., Angman, L., Jeno, P., Mori, L. & De Libero, G. (2003) Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. Journal of Experimental Medicine, 197, 163168.
  • Hewitt, R.E., Lissina, A., Green, A.E., Slay, E.S., Price, D.A. & Sewell, A.K. (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood γδ T cells in response to aminobisphosphonates is inhibited by statins. Clinical and Experimental Immunology, 139, 101111.
  • Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H.P. & Wilhelm, M. (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96, 384392.
  • Legay, F., Gauron, S., Deckert, F., Gosset, G., Pfaar, U., Ravera, C., Wiegand, H. & Schran, H. (2002) Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine. Journal of Pharmaceutical and Biomedical Analysis, 30, 897911.
  • Miyagawa, F., Tanaka, Y., Yamashita, S. & Minato, N. (2001) Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. Journal of Immunology, 166, 55085514.
  • Mönkkönen, H., Auriola, S., Lehenkari, P., Kellinsalmi, M., Hassinen, I.E., Vepsäläinen, J. & Mönkkönen, J.A. (2006) A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. British Journal of Pharmacology, 147, 437445.
  • Tanaka, Y., Morita, C.T., Tanaka, Y., Nieves, E., Brenner, M.B. & Bloom, B.R. (1995) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature, 375, 155158.
  • Thompson, K. & Rogers, M.J. (2004) Statins prevent bisphosphonate-induced gamma delta-T-cell proliferation and activation in vitro. Journal of Bone and Mineral Research, 19, 278288.
  • Thompson, K., Rojas-Navea, J. & Rogers, M.J. (2006a) Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood, 107, 651654.
  • Thompson, K., Rogers, M.J., Coxon, F.P. & Crockett, J.C. (2006b) Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Molecular Pharmacology, 69, 16241632.